Author Question: Last time we tried to automate the assembly line, it failed and cost us a lot to clean up the mess. ... (Read 10 times)

lak

  • Hero Member
  • *****
  • Posts: 546
Last time we tried to automate the assembly line, it failed and cost us a lot to clean up the mess. This is an example of an organizational barrier to change.
 
  Indicate whether the statement is true or false

Question 2

________ reveal exactly how long it takes to perform a task and the best way to perform it.
 
  A) Elapsed time analyses
  B) Time and motion studies
  C) Time-lapse investigations
  D) Productivity inspections

Question 3

Josh Bishoff is an industrial engineer who measures exactly how long a task takes and works on developing ways to complete the job in minimal time, including specifying the exact body movements workers should use to do the job most efficiently.
 
  The process he uses to develop the optimal way to perform a task is known as ________.
  A) time and motion studies
  B) horizontal job loading
  C) job enlargement
  D) job enrichment



maaaaaaaaaa

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

TRUE

Answer to Question 2

Boom Correct answer

Answer to Question 3

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

The most dangerous mercury compound, dimethyl mercury, is so toxic that even a few microliters spilled on the skin can cause death. Mercury has been shown to accumulate in higher amounts in the following types of fish than other types: swordfish, shark, mackerel, tilefish, crab, and tuna.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library